Swiss drug developer Roche boosted its hostile tender offer for biotechnology pioneer Genentech Inc to US$93 per share on Friday, raising the total offer value to US$45.7 billion, after its initial offer failed to pick up much support from shareholders.
For weeks, Genentech’s board had been calling Roche’s US$86.50 bid too low, with much of Wall Street saying shareholders likely wouldn’t bite at the offer.
In its statement on Friday, Roche said it received tenders for only 500,000 shares in the tender offer that was set to expire on Thursday, a tiny fraction of the 44 percent the company needs to take control of Genentech.
As of Feb. 6, Genentech has just more than 1.05 billion shares of common stock outstanding, of which Roche owned about 587.2 million.
It needs the support from a majority of the other shareholders to complete any deal.
The US$86.50 bid had been a surprise to many, following rejection of an US$89-per-share bid by Genentech’s board in July. The tender offer has been extended from Thursday to March 20.
In a Securities and Exchange Commission filing late on Friday, the company said it had raised about US$36 billion through a series of debt offerings. It expects to get the rest of the funding through a combination of debt financing, which could include private placements of notes, commercial paper and borrowings, or with available cash, the company said.
The latest statement from Roche didn’t say how the increased offer might affect its ability to raise additional funding.
“Based on conversations with Genentech shareholders, we believe that there is a strong sentiment to bring this process to a conclusion,” Roche Group chairman Franz Humer said in the statement. “As a result, we are increasing our price to US$93 per share to maximize shareholder participation and will proceed quickly to complete all necessary financing.”
Genentech advised its shareholders to take no action on the revised bid. A special committee of the board will make a formal statement soon, the company said.
On Monday, Genentech spent a four-hour meeting with analysts, detailing long-term sales and research projections to back up its assertion that the company was worth more than the Roche offer. In previous regulatory filings, Genentech said it could be worth up to US$112 per share.
NEW MARKET: The partnership opens up India to the Dutch company, which already has a strong hold in the semiconductor market of South Korea, Taiwan and China ASML Holding NV entered into a partnership agreement with Tata Electronics Pvt Ltd aimed at ramping up India’s goal to develop domestic chip-manufacturing capabilities. The Dutch company’s technology would help power Tata Electronics’ planned 300 millimeter (mm) semiconductor foundry in Gujarat, according to a joint statement from the two companies on Saturday. The signing of a memorandum of understanding coincides with a visit by Indian Prime Minister Narendra Modi to the Netherlands, which is looking to deepen bilateral relations with New Delhi. ASML, whose top customers include Taiwan Semiconductor Manufacturing Co (台積電) and Samsung Electronics Co, makes lithography machines that can print
TECH RELIANCE: Growth is increasingly reflecting an unequal K-shaped distribution, where technology sectors outperform and other industries struggle, an expert said Standard Chartered Bank has significantly raised its forecast for Taiwan’s economic growth to 9.5 percent this year, up from 7.6 percent previously, citing surging artificial intelligence (AI) demand driving exports, semiconductor production and investment. The upgrade reflects a sustained AI supercycle that continues to fuel demand for advanced chips and technology infrastructure, which form the backbone of Taiwan’s exports, the bank said in a report this week. “We raise our 2026 growth forecast to reflect a much stronger-than-expected first-quarter GDP figure,” Standard Chartered senior economist for greater China and Asia Tommy Wu (胡東安) said in the report. Driven largely by a 35.3 percent
Tokyo Electron's Taiwan unit today said in a written response that it respects the judicial process, takes the court ruling seriously and would not appeal in the Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) trade secrets case. Last month, a court fined the Taiwan unit of Japan's Tokyo Electron NT$150 million (US$4.74 million) in a case involving trade secrets related to TSMC's sensitive chip technology.
Two of Taiwan’s international carriers, Starlux Airlines Co (星宇航空) and EVA Airways Corp (長榮航空), have retained the five-star airline rating awarded by international airline review organization Skytrax. Starlux was awarded the distinction for a second consecutive year, while EVA Air received it for the 11th straight year, Skytrax said in statements released yesterday and on Thursday last week, respectively. The five-star rating is considered one of the airline industry's highest honors and is awarded following professional audits of airline product and frontline service standards, Skytrax said. The ratings are based on in-depth assessments using unified global quality standards rather than customer review scores
RSS